Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_4
2
67%
Ph phase_2
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(1)
Other(2)

Detailed Status

unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 21 (33.3%)
Phase 42 (66.7%)

Trials by Status

unknown267%
withdrawn133%

Recent Activity

0 active trials
Showing 3 of 3
withdrawnphase_4

Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian Responders

NCT05405686
unknownphase_2

Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men

NCT04189133
unknownphase_4

Comparison of Assisted Reproductive Technology (ART) Outcomes Between Two Protocols of Induction of Ovulation in Patients With Hypogonadotropic Hypogonadism

NCT02140515

Clinical Trials (3)

Showing 3 of 3 trials
NCT05405686Phase 4

Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian Responders

Withdrawn
NCT04189133Phase 2

Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men

Unknown
NCT02140515Phase 4

Comparison of Assisted Reproductive Technology (ART) Outcomes Between Two Protocols of Induction of Ovulation in Patients With Hypogonadotropic Hypogonadism

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3